Chris R. Dunk

3.7k total citations
5 papers, 143 citations indexed

About

Chris R. Dunk is a scholar working on Molecular Biology, Cancer Research and Biotechnology. According to data from OpenAlex, Chris R. Dunk has authored 5 papers receiving a total of 143 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Biotechnology. Recurrent topics in Chris R. Dunk's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Research and Treatments (2 papers) and Nanoplatforms for cancer theranostics (2 papers). Chris R. Dunk is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer Research and Treatments (2 papers) and Nanoplatforms for cancer theranostics (2 papers). Chris R. Dunk collaborates with scholars based in United Kingdom and Latvia. Chris R. Dunk's co-authors include Paul M. Loadman, Peter A. Harris, Mark R. Albertella, Roger M. Phillips, Alan Anthoney, N.G. Burnet, R. Rampling, Alvin Wong, Chris Twelves and Egils Vjaters and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Chris R. Dunk

4 papers receiving 139 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris R. Dunk United Kingdom	3	88	59	52	27	20	5	143
Judit Liaño-Pons Sweden	7	122 1.4×	189 3.2×	31 0.6×	36 1.3×	11 0.6×	12	276
Yulia Panina Russia	4	87 1.0×	102 1.7×	12 0.2×	14 0.5×	8 0.4×	8	158
Manabu Kodama Japan	5	160 1.8×	173 2.9×	19 0.4×	44 1.6×	18 0.9×	8	258
Patricia Altea‐Manzano Spain	10	158 1.8×	232 3.9×	37 0.7×	56 2.1×	8 0.4×	16	362
Tommy Weiss‐Sadan Israel	6	44 0.5×	78 1.3×	59 1.1×	27 1.0×	4 0.2×	8	198
Caroline R. Amendola United States	6	133 1.5×	214 3.6×	30 0.6×	111 4.1×	12 0.6×	6	319
Lourdes Sainero‐Alcolado Sweden	7	179 2.0×	221 3.7×	31 0.6×	31 1.1×	12 0.6×	7	342
Yexuan Deng China	6	46 0.5×	135 2.3×	36 0.7×	33 1.2×	5 0.3×	7	209
Guiping Yu China	12	140 1.6×	231 3.9×	20 0.4×	39 1.4×	7 0.3×	24	318
Jiaoyang Ning China	7	69 0.8×	146 2.5×	30 0.6×	86 3.2×	9 0.5×	11	277

Countries citing papers authored by Chris R. Dunk

Since Specialization

Citations

This map shows the geographic impact of Chris R. Dunk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris R. Dunk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris R. Dunk more than expected).

Fields of papers citing papers by Chris R. Dunk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris R. Dunk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris R. Dunk. The network helps show where Chris R. Dunk may publish in the future.

Co-authorship network of co-authors of Chris R. Dunk

This figure shows the co-authorship network connecting the top 25 collaborators of Chris R. Dunk. A scholar is included among the top collaborators of Chris R. Dunk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris R. Dunk. Chris R. Dunk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Williams, Kaye J., Mark R. Albertella, Brian Fitzpatrick, et al.. (2009). In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts. Molecular Cancer Therapeutics. 8(12). 3266–3275. 38 indexed citations

2.

Albertella, Mark R., Paul M. Loadman, Philip H. Jones, et al.. (2008). Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study. Clinical Cancer Research. 14(4). 1096–1104. 98 indexed citations

3.

Albertella, Mark R., Paul M. Loadman, Kaye J. Williams, et al.. (2006). In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts. 66. 314–314. 6 indexed citations

4.

Albertella, Mark R., et al.. (2005). The novel hypoxia-targeted anticancer agent AQ4N is not subject to multi-drug resistance mediated by PGP/MDR1. Cancer Research. 65. 123–124. 1 indexed citations

5.

Cleland, Jeffrey L., Alvin Wong, Susan E. Alters, et al.. (2004). A Novel N-Oxide Drug, AQ4N, Has In Vitro Activity in Lymphoma and Leukemia Cell Lines and Selectively Targets Lymphocytes and Lymphatic Tissues in Vivo.. Blood. 104(11). 2498–2498.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact